Development of improved Sindbis virus-based DNA expression vector

Area of Science:

• Molecular Biology
• Virology
• Gene Expression

Background:

• Development of efficient DNA expression vectors is crucial for gene therapy and research.
• Sindbis virus vectors offer potential for high-level gene delivery.
• Existing vectors have limitations in expression efficiency and applicability.

Purpose of the Study:

• To construct and evaluate an improved Sindbis virus-based DNA expression vector.
• To assess the efficiency of transgene expression in mammalian cells and in vivo.
• To investigate the vector's effect on glioma cell viability.

Main Methods:

• Construction of a recombinant Sindbis virus plasmid DNA vector (pSin-SV40-HDV-SV40pA) replacing structural genes with a polylinker.
• Transfection of mammalian cells and injection into mouse quadriceps to assess gene expression.
• Quantification of beta-galactosidase reporter gene expression.
• Evaluation of vector-induced apoptosis in glioma cells.

Main Results:

• The pSin-SV40-HDV-SV40pA vector achieved transient high-level expression of the beta-galactosidase gene in mammalian cells, exceeding previous vectors by over 16-fold.
• In vivo expression was detected in mouse quadriceps but was transient, disappearing after 14 days.
• Transfection with the Sindbis virus vector induced apoptotic death in glioma cells.

Conclusions:

• The novel Sindbis virus-based DNA vector, pSin-SV40-HDV-SV40pA, significantly enhances transgene expression efficiency.
• The vector shows potential for in vivo gene delivery and targeted cancer therapy due to its apoptotic effect on glioma cells.
• Further research is warranted to optimize in vivo persistence and explore therapeutic applications.